Clinical Trial Update: Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of erenumab in pediatric subjects with chronic migraine; study status indicates completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AIMOVIG (ERENUMAB-AOOE)

Snippet

Sponsor: Amgen | Conditions: Migraine | Phase 3 | Status: COMPLETED